Stay updated on RO6958688 Combination with Atezolizumab in CEA+ Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the RO6958688 Combination with Atezolizumab in CEA+ Solid Tumors Clinical Trial page.

Latest updates to the RO6958688 Combination with Atezolizumab in CEA+ Solid Tumors Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed descriptions of a clinical study involving RO6958688 and atezolizumab, while adding a new identifier and revision number.SummaryDifference29%
- Check35 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check42 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check78 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check93 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference1%
Stay in the know with updates to RO6958688 Combination with Atezolizumab in CEA+ Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RO6958688 Combination with Atezolizumab in CEA+ Solid Tumors Clinical Trial page.